Genetix Biotherapeutics Revenue

Biotechnology Research • Somerville, Massachusetts, United States • 51-100 Employees

Genetix Biotherapeutics revenue & valuation

Annual revenue	$5,304,410
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$17,000,000
Total funding	No funding

Key Contacts at Genetix Biotherapeutics

David Meek

Chief Executive Officer

Michael Grentzer

Senior Director Qualified Treatment Center Engagement

Lucinda Rogers

Associate Director, Patient Navigator

Kristen Lee

Associate Director, Commercial Strategy, Insights & Analytics

Percy L. Goode

Sr Director Qtc Account Lead

Robert Hill

Senior Director Finance - Controller

Jamail Ajaj

Director Qc Operations/Stability

Heather Caouette

Director Of Quality Control

Carly Duvall

Director, Commercial Operations

Judith Tauriac

Director

Company overview

Headquarters	Somerville, Massachusetts, United States
Website	genetixbiotx.com
NAICS	541714
Keywords	Gene Therapy, Sickle Cell Disease, Gene Addition, Beta-Thalassemia, Cerebral Adrenoleukodystrophy
Employees	51-100

Genetix Biotherapeutics Email Formats

Genetix Biotherapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@genetixbiotx.com), used 75% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@genetixbiotx.com	75%
{first name}{last name}	johndoe@genetixbiotx.com	25%

About Genetix Biotherapeutics

Genetix Biotherapeutics is dedicated to transforming lives through curative therapies. Formerly bluebird bio, Genetix Biotherapeutics Inc. Is a privately held, commercial-stage biotechnology company dedicated to delivering genetic therapies for patients with severe rare diseases. The company has three FDA-approved genetic therapies for patients living with sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy. These first-in-class, one-time administered therapies treat the underlying cause of disease and can offer significant and lasting benefits to patients and their families. Genetix is now better positioned to harness its decades of scientific innovation and extensive clinical data from hundreds of treated patients to more effectively deliver life-changing genetic therapies. As we enter this new era, Genetix Biotherapeutics is building an ecosystem to expand awareness and access for thousands of untreated patients. Rooted in decades of scientific innovation, we are sharpening our focus on commercial execution, scaling patient access, and enhancing the treatment experience for patients, families, and providers. Community guidelines: bit.ly/4nAuCWY

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Director

Manager

Senior

Employees by Department

Genetix Biotherapeutics has 30 employees across 9 departments.

Departments

Number of employees

Funding Data

Genetix Biotherapeutics has never raised funding before.

Frequently asked questions

Genetix Biotherapeutics is located in Somerville, Massachusetts, US.

Genetix Biotherapeutics generates an estimated annual revenue of $5,304,410. This revenue figure reflects the company's market position and business performance in its industry.

Genetix Biotherapeutics has an estimated valuation of $17,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Genetix Biotherapeutics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.